West Nile fever characteristics among viremic persons identified through blood donor screening

Journal of Infectious Diseases

Volumn 202, Issue 9, 2010, Pages 1354-1361

  Zou, Shimian ^a   Foster, Gregory A ^b   Dodd, Roger Y ^a   Petersen, Lyle R ^c   Stramer, Susan L ^b  

^a HOLLAND LABORATORY   (United States)

^b AMERICAN RED CROSS   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; NUCLEIC ACID; VIRUS RNA;

ABDOMINAL PAIN; ADULT; ARTHRALGIA; ARTICLE; BLOOD DONOR; BONE PAIN; CHILL; DIARRHEA; EAST COAST FEVER; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INTERVIEW; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MYALGIA; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; SYMPTOM; TREMOR; VIREMIA; VIRUS INFECTION; VIRUS LOAD; VOMITING; WEST NILE FEVER; AGED; BLOOD; GENETICS; MASS SCREENING; MIDDLE AGED; PATHOLOGY; UNITED STATES; WEST NILE FLAVIVIRUS;

ADULT; AGED; BLOOD DONORS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RNA, VIRAL; UNITED STATES; VIRAL LOAD; WEST NILE FEVER; WEST NILE VIRUS;

EID: 77958091046     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/656602     Document Type: Article

References (25)

1. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA 2003; 290:524-528.
2. Huhn GD, Sejvar JJ, Montgomery SP, Dworkin MS. West Nile virus in the United States: an update on an emerging infectious disease. Am Fam Physician 2003; 68:653-660.
3. Hayes EB, Gubler DJ. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med 2006; 57:181-194.
4. Busch MP, Wright DJ, Custer B, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis 2006; 12:395-402.
5. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352:767-771.
6. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358:261-264.
7. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005; 353:451-459.
8. Busch MP, Caglioti S, Robertson EF, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005; 353:460-467.
9. Petersen LR, Epstein JS. Problem solved? West Nile virus and transfusion safety. N Engl J Med 2005; 353:516-517.
10. Stramer SL, Custer B, Busch MP, Dodd RY. Strategies for testing blood donors for West Nile virus. Transfusion 2006; 46:2036-2037.
11. Orton SL, Stramer SL, Dodd RY. Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors. Transfusion 2006; 46(2):272-277.
12. Brown JA, Factor DL, Tkachenko N, et al. West Nile viremic blood donors and risk factors for subsequent West Nile fever. Vector Borne Zoonotic Dis 2007; 7:479-488.
13. Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP. Association between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion 2009; 49:278-288.
14. AABB. West Nile Virus-revised recommendations for triggering individual donation nucleic acid testing and use of communication plans. Assoc Bull 2008; 03:1-6.
15. Biggerstaff BJ, Petersen LR. A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing forWest Nile virus. Transfusion 2009; 49:1151-1159.
16. Stramer SL, Foster G, Krysztof D, Dodd RY. Evaluation of triggering strategies for single unit NAT West Nile virus [abstract S60-030D]. Transfusion 2008; 48(2S):23A-24A.
17. Stramer SL, Foster GA, Townsend RL, Krysztof D, Dodd RY. Evaluation of the yield of triggering and detriggering criteria for West Nile virus (WNV) NAT [abstract S69-030G]. Transfusion 2009; 49(3S):30A.
18. Stramer SL, Brodsky JP, Caglioti S, Strong DM. Confirmation of in fection among donors identified by minipool and individual donation Nucleic Acid Testing (NAT) for West Nile Virus (WNV) in the United States from 2003-2005 [abstract P5-030A]. Transfusion 2006; 46(Suppl. 9S):2A.
19. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008; 198:984-993.
20. SAS/STAT user's guide, version 6. 4th ed. Cary, NC: SAS Institute, 1989.
21. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system, 2nd ed. Cary, NC: SAS Institute, 2003:347-362.
22. Jean CM, Honarmand S, Louie JK, Glaser CA. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis 2007; 13:1918-1920.
23. Petersen LR, Hayes EB. West Nile virus in the Americas. Med Clin North Am 2008; 92:1307-1322, ix.
24. Centers for Disease Control and Prevention. Surveillance for human West Nile virus disease - United States, 1999-2008. MMWR Morb Mort Wkly Rep 2010; 59 (SS-2):1-18.
25. Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med 2004; 141:360-365.